PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 199 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $258,000 | -15.4% | 8,000 | -10.1% | 0.01% | -31.6% |
| Q3 2016 | $305,000 | -73.0% | 8,900 | -67.6% | 0.02% | -62.0% |
| Q3 2015 | $1,130,000 | -9.2% | 27,500 | +96.4% | 0.05% | -9.1% |
| Q1 2015 | $1,244,000 | -12.3% | 14,000 | -12.5% | 0.06% | +12.2% |
| Q4 2014 | $1,419,000 | +22.0% | 16,000 | +33.3% | 0.05% | +75.0% |
| Q3 2014 | $1,163,000 | -15.6% | 12,000 | -20.0% | 0.03% | -6.7% |
| Q2 2014 | $1,378,000 | +96.9% | 15,000 | +50.0% | 0.03% | +114.3% |
| Q1 2014 | $700,000 | – | 10,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 550,000 | $18,442,000 | 6.98% |
| Gagnon Advisors, LLC | 193,860 | $6,500,000 | 6.06% |
| GAGNON SECURITIES LLC | 407,159 | $13,652,000 | 4.64% |
| Spyglass Capital Management LLC | 1,190,537 | $39,919,000 | 4.51% |
| Paulson & Co. | 1,716,727 | $57,562,000 | 2.20% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,627,521 | $54,571,000 | 1.73% |
| Elk Creek Partners, LLC | 265,146 | $8,890,000 | 1.53% |
| HealthCor Management, L.P. | 887,370 | $29,754,000 | 1.27% |
| Rock Springs Capital Management LP | 900,000 | $30,177,000 | 1.25% |
| Lisanti Capital Growth, LLC | 108,679 | $3,644,000 | 1.20% |